MAPT and early-onset autosomal dominant Alzheimer disease: As highlighted by Zhongcong Xie’s work, targeting tau hyperphosphorylation represents a promising therapeutic strategy to mitigate anesthesia-induced neural network impairments and retrograde amnesia in Alzheimer’s disease (Chen et al., 2024).